YD Bio Ltd (YDES)
$4.15+$0.28 (+7.24%) Today
YD Bio Ltd is a biotechnology company focused on regulated diagnostics, life science clinical services and healthcare product commercialization. Its operations include DNA methylation-based oncology testing programs in the United States under an LDT framework with CLIA-certified and CAP-accredited laboratory partners. The Company also provides life science distribution and clinical trial supply chain services, including procurement, logistics coordination and compliance-focused support for clinical development programs. It maintains ocular health product commercialization operations in the United States and consumer healthcare distribution activities in Asia. The Company operates in the United States and Taiwan, with Taiwan generating maximum revenue.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 2 | 11,498 | |
| Option exercise | 4 | 22,996 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
4 Form 4 filings on record, the earliest from Apr 2, 2026, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shao-Ta Lu - Director | Option exercise | Ordinary Shares | 5,749 | - | - | |
| Shao-Ta Lu - Director | Grant or award | Restricted Share Units | 5,749 | $0.00 | - | |
| Shao-Ta Lu - Director | Option exercise | Restricted Share Units | 5,749 | $0.00 | - | |
| Kochi Chang - Director | Option exercise | Ordinary Shares | 5,749 | - | - | |
| Kochi Chang - Director | Grant or award | Restricted Share Units | 5,749 | $0.00 | - | |
| Kochi Chang - Director | Option exercise | Restricted Share Units | 5,749 | $0.00 | - | |
| Shao-Ta Lu - Director | Option exercise | Ordinary Shares | 2,081 | - | - | |
| Shao-Ta Lu - Director | Grant or award | Restricted Share Units | 2,081 | $0.00 | - | |
| Shao-Ta Lu - Director | Option exercise | Restricted Share Units | 2,081 | $0.00 | - | |
| Kochi Chang - Director | Option exercise | Ordinary Shares | 2,081 | - | - | |
| Kochi Chang - Director | Grant or award | Restricted Share Units | 2,081 | $0.00 | - | |
| Kochi Chang - Director | Option exercise | Restricted Share Units | 2,081 | $0.00 | - |
YD Bio Ltd (YDES) had 2 insider filings in the last 90 days, with the most recent on 2026-07-01. The full record for YDES runs to 4 Form 4 filings, the earliest from 2026-04-02. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of YDES were filed in the last 90 days.
No insider sales of YDES were filed in the last 90 days.
This page tracks YDES Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add YDES to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
